In patients with pancreatic cancer, the occurrence of allelic imbalance at the KRAS locus is associated with reduced survival (Fig. 1A; ref. 3) and early progression, as previously reported (2, 5). The gene discussed is KRAS; the disease is pancreatic neoplasm.